Sequence-Based Nanobody-Antigen Binding Prediction
Usama Sardar, Sarwan Ali, Muhammad Sohaib Ayub, Muhammad Shoaib,, Khurram Bashir, Imdad Ullah Khan, Murray Patterson

TL;DR
This paper introduces a sequence-based machine learning method for predicting nanobody-antigen binding with high accuracy, bypassing the need for 3D structural data and enabling faster screening of potential nanobodies.
Contribution
The study presents a novel gapped k-mer embedding approach combined with machine learning to predict nanobody-antigen interactions solely from sequence data, improving efficiency over traditional methods.
Findings
Achieves up to 90% accuracy in binding prediction.
Significantly faster than computational docking techniques.
Provides a practical tool for nanobody screening without structural data.
Abstract
Nanobodies (Nb) are monomeric heavy-chain fragments derived from heavy-chain only antibodies naturally found in Camelids and Sharks. Their considerably small size (~3-4 nm; 13 kDa) and favorable biophysical properties make them attractive targets for recombinant production. Furthermore, their unique ability to bind selectively to specific antigens, such as toxins, chemicals, bacteria, and viruses, makes them powerful tools in cell biology, structural biology, medical diagnostics, and future therapeutic agents in treating cancer and other serious illnesses. However, a critical challenge in nanobodies production is the unavailability of nanobodies for a majority of antigens. Although some computational methods have been proposed to screen potential nanobodies for given target antigens, their practical application is highly restricted due to their reliance on 3D structures. Moreover,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMonoclonal and Polyclonal Antibodies Research · Glycosylation and Glycoproteins Research · vaccines and immunoinformatics approaches
